OrganOx Ltd.
OrganOx is dedicated to transforming organ transplantation by developing innovative products that increase the number of donor organs available for transplant and improve outcomes. Their flagship product, the _metra ®_, harnesses patented normothermic machine perfusion technology to preserve donor livers for up to 24 hours prior to transplant, enabling functional assessment and evidence-based decisions. The company aims to save lives by making every donated organ count, addressing the shortage of transplantable organs and reducing urgency in transplantation procedures.
Industries
Nr. of Employees
small (1-50)
OrganOx Ltd.
3500 John Smith Drive, Oxford Business Park, Oxford, OX4 2WB, UK
Patents
Products
Normothermic liver perfusion system
A transportable, automated perfusion system that maintains donor livers at near-physiological temperature using oxygenated blood, supports continuous monitoring of perfusate and bile, and enables pre-transplant functional assessment and extended preservation times.
Normothermic liver perfusion system
A transportable, automated perfusion system that maintains donor livers at near-physiological temperature using oxygenated blood, supports continuous monitoring of perfusate and bile, and enables pre-transplant functional assessment and extended preservation times.
Services
Provision of normothermic perfusion systems and single-use consumable circuits plus on-boarding support for transplant centres including training and technical assistance.
Collaboration with clinical centres on randomized trials, observational studies and publications to evaluate perfusion protocols, viability criteria and clinical outcomes.
Provision of regulatory-compliant instructions for use, safety and performance documentation and advisory support for regulatory submissions.
Provision of normothermic perfusion systems and single-use consumable circuits plus on-boarding support for transplant centres including training and technical assistance.
Collaboration with clinical centres on randomized trials, observational studies and publications to evaluate perfusion protocols, viability criteria and clinical outcomes.
Provision of regulatory-compliant instructions for use, safety and performance documentation and advisory support for regulatory submissions.
Expertise Areas
- Normothermic liver perfusion and organ preservation
- Clinical trial management and evidence generation
- Medical device development and commercial manufacturing
- Regulatory strategy and quality management for medical devices
Key Technologies
- Normothermic machine perfusion (NMP)
- On-board blood gas and perfusate chemistry monitoring
- Real-time perfusion control algorithms and graphical UIs
- Integrated oxygenation and heater subsystems
News & Updates
TTS Annual Congress
September 12-17, 2020, Seoul, South Korea
AOPO Annual Meeting
June 22-25, 2020, San Antonio, Texas
ATC Congress
May 30, 2020, Philadelphia, Pennsylvania
ILTS Annual Congress
May 6-9, 2020, Istanbul, Turkey
British Transplant Society annual congress
March 4-6, 2020, Belfast, Northern Ireland
International Transplant Symposium
January 7, 2020, Leuven, Belgium
TTS Annual Congress
September 12-17, 2020, Seoul, South Korea
AOPO Annual Meeting
June 22-25, 2020, San Antonio, Texas
ATC Congress
May 30, 2020, Philadelphia, Pennsylvania
ILTS Annual Congress
May 6-9, 2020, Istanbul, Turkey
British Transplant Society annual congress
March 4-6, 2020, Belfast, Northern Ireland
International Transplant Symposium
January 7, 2020, Leuven, Belgium